Also Read

India currently has approximately 77 mn diabetes patients, the second highest in the world. A diabetic foot ulcer is one of the most significant and devastating complications of diabetes and is defined as a foot affected by ulceration that is associated with neuropathy and/or peripheral arterial disease of the lower limb in a patient with diabetes. Approximately, 12-15% with diabetes suffer from DFU at least once in a lifetime. 5–24% of them will finally lead to limb amputation within 6–18 months after the first evaluation. The risk of foot ulceration and limb amputation increases with age and the duration of diabetes. Alkem has collaborated with Rokit Healthcare Inc. to commercialize the technology in India to help reduce amputation amongst DFU patients considering the negative impact of amputation on a patient’s quality of life and the associated economic burden on the healthcare system.
Mr. Sandeep Singh, Managing Director, Alkem Laboratories Ltd., stated, “In India, Diabetes is one of the major healthcare challenges. The challenge in itself is so huge that diabetic foot ulcers often get ignored. Approximately 1 lac people have to undergo amputation every year and compromise on their quality of life. To address the problem, Alkem has collaborated with Rokit Healthcare Inc., a global regenerative solutions company, to bring out novel solutions for the management of diabetic foot ulcers.”
Adding further, Mr. Sandeep asserted, “Alkem, over the years, has always been at the forefront in delivering high-quality patient care, through its innovation and patient-centric initiatives.”
About Alkem Laboratories Ltd.:
Established in 1973 and headquartered in Mumbai, Alkem (NSE: ALKEM, BSE: 539523) is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and International markets. With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales (Source: IQVIA March 2021). The Company also has presence in more than 40 international markets, with the United States being its key focus market.
For more information on Alkem Laboratories Ltd., please visit www.alkemlabs.com
Photo: https://mma.prnewswire.com/media/1724812/Sandeep_Singh.jpg
(This story is auto-generated from PR Newswire)
Related Posts
-
Coronavirus Vaccine Prices In India and Other Countries. Is Covid Vaccine Free?
-
Padma Vibhushan, Padma Bhushan, Padma Shri: Full List Of Padma Award Winners 2021
-
Importance And Benefits Of Vitamin D Rich Food
-
Yoga Beginner’s Guide – Tips Before Attending The First Yoga Class
-
Parliament of India: नया देश नया भवन
Recent Posts
- Azadi Ka Amrit Mahotsav: From August 5–15, visit these Indian Tourist Places For FREE
- #AzadiKaAmritMahotsav: Dos and Don’ts of Hoisting the National Flag at home
- Steps To Download Covid-19 Vaccine Certificate Using Whatsapp
- Celebrate International Cat Day (World Cat Day) On 8 August
- Meet Neeraj Chopra Who Won 1st Gold Medal For India In Tokyo Olympics 2021